Sai Life Sciences’ ₹3,042 crore IPO opens today, closing December 13. The offer includes a fresh issue and an OFS, aiming to repay debt. Priced at ₹522-549 per share, analysts advise caution due to high valuation and OFS-heavy structure, despite strong financial performance.
Kaynes shares plunge 43% from October peak. Is a tactical rebound on the cards or more pain ahead?
Kaynes has plunged 43.5% from its October peak, with Friday’s 12.5% drop marking the steepest single-day decline. Momentum indicators remain bearish, signaling a risk of